Altos Labs’ Quest for Immortality: Dr. Blagosklonny’s Perspective | Aging-US
Channel: Aging (Aging-US)
Date: 11/05/2022

Oncoscience published this trending research perspective in Volume 9, 2022, entitled, "Altos Labs and the quest for immortality: but can we live longer right now?" by Dr. Mikhail V. Blagosklonny from Roswell Park Cancer Institute, Buffalo, NY. 

DOI - https://doi.org/10.18632/oncoscience.552

Corresponding author - Mikhail V. Blagosklonny - Blagosklonny@oncotarget.com, Blagosklonny@rapalogs.com

Abstract

Some visionaries prefer to dream of immortality rather than to actually live longer. Here I discuss how combining rapamycin with other modalities may let us live long enough to benefit from future discoveries in cellular reprogramming and what needs to be done at Altos Labs to make this happen.

Press release - https://aging-us.com/news_room/altos-labs-quest-for-immortality

Keywords - aging, longevity, lifespan, geroscience, rapalogs, gerostatics

About Oncoscience

Oncoscience's mission is to cover the rapidly growing field of cancer research. It’s aim is to focus on emergent topics not currently covered by other journals.

Launched in 2014, Oncoscience is a peer-reviewed, traditional-style, bi-monthly journal with free access. Oncoscience also has a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

Please visit our website at https://www.oncoscience.us/ and connect with us:

Facebook - https://www.facebook.com/Oncoscience/
Twitter - https://twitter.com/OncoscienceJrnl
LinkedIn - https://www.linkedin.com/company/oncoscience/
YouTube - https://www.youtube.com/oncoscience

Oncoscience is published by Impact Journals, LLC: http://www.ImpactJournals.com​​

Media Contact
18009220957
MEDIA@IMPACTJOURNALS.COM